130 results on '"Christensen, S."'
Search Results
2. P364 Fat and glucose metabolism during exercise in patients with methylmalonic and propionic acidemia
3. Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers
4. Implementation of a Dedicated HDR Peer Review Program can Result in Improved Total Treatment Times for Gynecological Patients
5. Implementation of a Dedicated Concurrent Chemotherapy and Radiation (C-XRT) Coordination Process can Result in Improved C-XRT Synchronization
6. Healthcare cost variation in patients with heart failure: a nationwide study
7. Intake design for an Atmosphere-Breathing Electric Propulsion System (ABEP)
8. The Faroe Islands - A possible founder population with a very high prevalence of familial hypercholesterolemia
9. Corrigendum to “SSP-27: 89Zr-immuno-PET of a novel bispecific amyloid β monoclonal antibody reveals improved and high specific brain uptake” [Nucl Med Biol (2020) Volumes 96–97, Supplement. S30-S31]
10. In-orbit aerodynamic coefficient measurements using SOAR (Satellite for Orbital Aerodynamics Research)
11. Gender Disparities in Philanthropic Fundraising by Academic Oncologists
12. Single Muscle Fibre Contractility Testing in Rats to Quantify Ischaemic Muscle Damage During Reperfusion Injury
13. Alpha-Linolenic Acid Intake And The Risk Of Atherosclerotic Cardiovascular Disease
14. Alpha-linolenic acid and risk of peripheral arterial disease
15. EPA and DHA in adipose tissue and the risk of ischemic stroke -a Danish case-cohort study
16. Serum content of saturated fatty acids and the prevalence of atrial fibrillation - A norwegian cross-sectional study
17. Return to work after cardiac surgery
18. Scaling up HCV-DAA treatment in patients on opioid substitution therapy (OST) – does alcohol and cannabis diminish cure rates? Data from the German Hepatitis C-Registry (DHC-R)
19. Significant changes of HCV patient characteristics over time in the era of direct antiviral agent therapy – are all HCV subpopulations treated similarly? – Results from the German hepatitis C Cohort
20. Can HCV be eliminated among HIV-infected MSM in Berlin? Modeling a setting with increasing incidence and high treatment rates
21. Has increased rollout of DAA therapy decreased the burden of late presentation and advanced liver disease in patients starting HCV therapy in Germany?
22. Acute bilateral experimental neck pain reorganises axioscapular and trunk muscle activity during slow arm movements
23. Does Sofosbuvir (SOF)/Velpatasvir (VEL) with or without Ribavirin (RBV) change the landscape of therapy in chronic hepatitis C genotype 3 (GT 3) infection? – Results from the GErman hepatitis C COhort (GECCO)
24. Effect of eradicating hepatitis C on alanine aminotransferase levels
25. Comparison of fatty acid composition of subcutaneous, pericardial and epicardial adipose tissue and atrial tissue in patients with heart disease
26. (421) A novel, non-opioid, conesnail peptide-based analgesic as a therapeutic alternative for the treatment of chronic pain
27. Ledipasvir/Sofosbuvir Treatment for 8 Weeks in Treatment-Naïve HCV Genotype 1 Infected Patients under Real Life Conditions: Data from the German Hepatitis C-Registry (DHC-R)
28. Treatment of Patients with Hepatitis C Virus (HCV) Genotype 3 Infection in the Era of Direct Acting Antivirals (DAA): Data from the German Hepatitis C-Registry (DHC-R)
29. Parameters Associated with Treatment Failure with Direct Acting Antivirals against the Hepatitis C Virus (HCV) – Results Fro the German Hepatitis C Cohort (GECCO)
30. Relapse and Treatment-Emergent RAVS with DAA-Based Regimens in Hepatitis C Virus (HCV) Mono- or Human Immunodeficiency Virus (HIV)-HCV Co-Infected Patients – a Real Concern in Clinical Practice? Results from the German Hepatitis C Cohort (GECCO)
31. Real-World Safety and Effectiveness of Ombitasvir/ Paritaprevir/R with Dasabuvir and/or Ribavirin in the German Hepatitis C Registry
32. Sleep stability and transitions in patients with idiopathic REM sleep behavior disorder and patients with Parkinson's disease
33. Marine n-3 PUFA content varies significantly between platelets and leucocytes – Implications for evaluating dietary compliance
34. Marine N-3 polyunsaturated fatty acids lower PCSK9 levels in pre- and postmenopausal women: A randomized study
35. Substance Abuse and Left Ventricular Assist Device Outcomes: Does a History and Type of Use Matter?
36. P0835 : German multicenter cohort on sofosbuvir-based treatments in HCV mono- and HIV/HCV co-infected patients (GECOSO)
37. (401) Analgesic effectiveness of a new, extended-release ibuprofen in postoperative dental pain
38. Effect of High-Intensity Training Versus Moderate Training on Peak Oxygen Uptake and Chronotropic Response in Heart Transplant Recipients: A Randomized Crossover Trial
39. P1046: Data-driven modeling of sleep EEG and EOG reveals stages indicative of pre-Parkinson and Parkinson’s disease
40. P1149 PHYSICIAN ADHERENCE TO AND EFFICACY OF TRIPLE THERAPY WITH TELAPREVIR (TVR) PLUS PEGINTERFERON ALFA-2a/RIBAVIRIN (PEGIFN/RBV) IN A REAL-LIFE SETTING
41. P1148 BASELINE FACTORS ASSOCIATED WITH SUSTAINED VIROLOGIC RESPONSE (SVR) IN PATIENTS TREATED WITH FIRST GENERATION PROTEASE INHIBITORS PLUS PEGINTERFERON ALFA-2a (40KD) AND RIBAVIRIN
42. Computational formulation of a new composite matrix
43. Serotonin transporter protein (SERT) and P-glycoprotein (P-gp) binding activity of montanine and coccinine from three species of Haemanthus L. (Amaryllidaceae)
44. 830 CHOLESTEROL LEVELS AND PRESENCE OF DIABETES PREDICT EARLY VIROLOGICAL RESPONSE TO TRIPLE THERAPY WITH TELAPREVIR, PEG-INTERFERON alfa-2a 180 μg AND RIBAVIRIN IN CHRONIC HEPATITIS C
45. 805 WEEK 4 AND 12 EFFICACY OF TELAPREVIR (TVR) IN COMBINATION WITH PEGINTERFERON alfa 2a/RIBAVIRIN (P/R) IN TREATMENT EXPERIENCED PATIENTS WITH GT-1 UNDER REAL LIFE CONDITIONS
46. 871 REAL-WORLD EFFICACY AND SAFETY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY
47. PO-0953: Implementing IGRT in daily practice
48. Flaxseed dietary fibers suppress postprandial lipemia and appetite sensation in young men
49. Alkaloid analysis by high-performance liquid chromatography-solid phase extraction-nuclear magnetic resonance: New strategies going beyond the standard
50. No effect of high-dose atorvastatin on leukotriene B4 formation from neutrophils in patients treated with coronary bypass surgery
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.